Navegar por autor "García Mata, Jesús"

A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study

2011- Antolín Novoa, Silvia; García Mata, Jesús; Álvarez Gómez, Elena; Mel Lorenzo, José Ramón; De Paz Arias , Laura [et al.]

Breast cancer management in the elderly

2014- Calvo Martínez, Lourdes; García Mata, Jesús; Cueva Bañuelos, Juan Fernando

Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists

2019- Sanchez-Rovira, P.; Zamora, P.; Salvador-Bofill, J.; Morales, S.; Martinez-Janez, N.; [et al.]

CASCADE study: Epidemiological analysis of current natural history and treatment patterns of metastatic breast cancer in spain

2015- García Mata, Jesús; De Paz Arias , Laura

Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report

2019- ARIAS RON, DAVID; LABANDEIRA GUERRA, CARMEN MARIA; Areses Manrique, María Carmen; SAMPEDRO DOMARCO, PAULA; Abdulkader Nallib, Ihab; [et al.]

Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)

2011- Fernández Calvo, Ovidio; García Mata, Jesús; Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; [et al.]

Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention

2017-09- Cueva Bañuelos, Juan Fernando; Antolín Novoa, Silvia; Calvo Martínez, Lourdes; Fernández, I; Ramos, M; [et al.]

Management of patients with metastatic breast cancer

2011- García Mata, Jesús

Non-randomized, open label phase II trial evaluating the safety and efficacy of taxotere (T) followed by myocet (M) + cyclophosphamide (C) as first-line treatment for HER2-negative breast cancer (BC)

2011- Calvo Martínez, Lourdes; García Mata, Jesús; López López, Rafael; Castellanos Diez, Javier

Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cancer (NS-NSCLC). A Galician Lung Cancer Group Study.

2015- Afonso Afonso, Francisco Javier; Anido Herranz, Urbano; Fernández Nuñez, Natalia; García Mata, Jesús; Firvida Perez, Jose Luis; [et al.]

Prevalence of cancer-related pain in different tumor entities, atlas study in Spanish oncology units

2015- Constenla Figueiras, Manuel; García Mata, Jesús; Vázquez Estévez, Sergio

Prevalence of cancer-related pain in different tumor entities: ATLAS Study in Spanish oncology units

2015- Constenla Figueiras, Manuel; García Mata, Jesús; Vázquez Estévez, Sergio

Primary malignant melanoma of the biliary tract: A case report and literature review

2019- CAMESELLE GARCIA, SOLEDAD; Perez, J. L. F.; Areses Manrique, María Carmen; Fernández De Castro, Jesús Daniel; Mosquera-Reboredo, J.; [et al.]

Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer

2011- García Mata, Jesús

SEOM guide to antiemetic prophylaxis in cancer patients treated with chemotherapy 2013

2013- García Mata, Jesús; Alonso Bermejo, Miguel Angel; Pérez López, María Eva; García. Gómez, Jesús

SEOM guideline for the treatment of malignant glioma

2012- García Mata, Jesús

Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report.

2020- ARIAS RON, DAVID; LABANDEIRA GUERRA, CARMEN MARIA; CAMESELLE GARCIA, SOLEDAD; García Mata, Jesús; Salgado Fernández, Mercedes [et al.]

TF expressed by microparticles is associated with mortality but not with thrombosis in cancer patients

2013- García Mata, Jesús; Hernández Sánchez, María Carmen

Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients

2013- García Mata, Jesús; Álves Pérez, María Teresa; Hernández Sánchez, María Carmen

Triple negative breast cancer (TNBC): clinical utility of immunohistochemical classification

2015- García Mata, Jesús; Penín Corderi, María del Carmen; Pérez López, María Eva; Arias Ron, David

Repositorio digital RUNA

Navegar por autor "García Mata, Jesús"

A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study ﻿

Breast cancer management in the elderly ﻿

Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists ﻿

CASCADE study: Epidemiological analysis of current natural history and treatment patterns of metastatic breast cancer in spain ﻿

Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report ﻿

Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09) ﻿

Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention ﻿

Management of patients with metastatic breast cancer ﻿

Non-randomized, open label phase II trial evaluating the safety and efficacy of taxotere (T) followed by myocet (M) + cyclophosphamide (C) as first-line treatment for HER2-negative breast cancer (BC) ﻿

Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cancer (NS-NSCLC). A Galician Lung Cancer Group Study. ﻿

Prevalence of cancer-related pain in different tumor entities, atlas study in Spanish oncology units ﻿

Prevalence of cancer-related pain in different tumor entities: ATLAS Study in Spanish oncology units ﻿

Primary malignant melanoma of the biliary tract: A case report and literature review ﻿

Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer ﻿

SEOM guide to antiemetic prophylaxis in cancer patients treated with chemotherapy 2013 ﻿

SEOM guideline for the treatment of malignant glioma ﻿

Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report. ﻿

TF expressed by microparticles is associated with mortality but not with thrombosis in cancer patients ﻿

Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients ﻿

Triple negative breast cancer (TNBC): clinical utility of immunohistochemical classification ﻿

A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study

Breast cancer management in the elderly

Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists

CASCADE study: Epidemiological analysis of current natural history and treatment patterns of metastatic breast cancer in spain

Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report

Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)

Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention

Management of patients with metastatic breast cancer

Non-randomized, open label phase II trial evaluating the safety and efficacy of taxotere (T) followed by myocet (M) + cyclophosphamide (C) as first-line treatment for HER2-negative breast cancer (BC)

Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cancer (NS-NSCLC). A Galician Lung Cancer Group Study.

Prevalence of cancer-related pain in different tumor entities, atlas study in Spanish oncology units

Prevalence of cancer-related pain in different tumor entities: ATLAS Study in Spanish oncology units

Primary malignant melanoma of the biliary tract: A case report and literature review

Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer

SEOM guide to antiemetic prophylaxis in cancer patients treated with chemotherapy 2013

SEOM guideline for the treatment of malignant glioma

Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report.

TF expressed by microparticles is associated with mortality but not with thrombosis in cancer patients

Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients

Triple negative breast cancer (TNBC): clinical utility of immunohistochemical classification